вЂњThis had been a low-volume business,вЂќ Sause told the summit. Suddenly, Roche was being called upon to supply six times its previous volume of polymerase-chain reaction (PCR) tests for the coronavirus that comprised the front line in health authoritiesвЂ™ arsenal. He leads more than 3,000 people in Indianapolis who develop and make diagnostic products for cancer, cardiac health and other conditions-as well as infectious diseases. The onset of the pandemic in early 2020 created an вЂњall-hands-on-deck momentвЂќ across the North American headquarters for the worldвЂ™s largest biotech company, headquartered in Switzerland, said Matt Sause, president and CEO of Roche Diagnostics North America. In a presentation from Roche Diagnostics, we heard how theyвЂ™ve embarked on dramatic overhauls of their supply chains that were prompted and accelerated by their response to Covid. In total, the company is connected to 3 other companies through its directors.At our recent Smart Manufacturing Summit in Indianapolis, supply chain disruption was very much top of mind among the CEOs that were on hand from across the country. Simpson Emmanuel Vinod Kumar has the largest number of other directorships with a seat at a total of 5 companies. The most recently appointed director is Narendra Sujit Varde, who was appointed on 12 January, 2021. Brajesh Rameshwardas Daga has been on the board for more than 6 years. The longest serving director currently on board is Brajesh Rameshwardas Daga who was appointed on 01 April, 2016. The company has 4 directors and 1 reported key management personnel. The registered office of Roche Diagnostics India Private Limited is at 501B, SILVER UTOPIA, CARDINAL GRACIOUS ROAD, CHAKALA, ANDHERI EAST, MUMBAI, Maharashtra. The Corporate Identification Number (CIN) of Roche Diagnostics India Private Limited is U85195MH1988PTC141417. Roche Diagnostics India Private Limited has four directors - Brajesh Rameshwardas Daga, Simpson Emmanuel Vinod Kumar, and others. Also, as per our records, its last balance sheet was prepared for the period ending on 31 March, 2021. The last reported AGM (Annual General Meeting) of Roche Diagnostics India Private Limited, per our records, was held on 28 September, 2021. The current status of Roche Diagnostics India Private Limited is - Active. Products & Services: prevention, diagnosis, treatment, evaluation, and monitoring of diseases systems and reagents for life science research Other performance and liquidity ratios are available here.Дescription: The company develops diagnostic systems and devices for patients, clinicians, and researchers. At the same time, it's book networth has increased by 9.08 %.

It's EBITDA has increased by 6.78 % over the previous year. Roche Diagnostics India's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2021.

It's authorized share capital is INR 18.00 cr and the total paid-up capital is INR 14.92 cr. It is classified as a private limited company and is located in Mumbai, Maharashtra. Roche Diagnostics India Private Limited is an unlisted private company incorporated on 07 June, 1988. OVERVIEW - ROCHE DIAGNOSTICS INDIA PRIVATE LIMITED

Roche diagnostics